Wednesday, February 10, 2010, 2:14PM AEST - The Australian Stockmarket closes in 1 hour and 51 minutes.
To create a watchlist or portfolio of shares, Register

AMAG Pharmaceuticals, Inc. (AMAG)

 8:00AM AEST: 36.08 USD  Down 0.59 (1.61%)  
 MORE ON AMAG 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 AMAG Pharmaceuticals, Inc. (NGM:AMAG) Delayed quote dataEdit
Last Trade:36.08 USD
Trade Time: 8:00AM AEST
Change:Down 0.59 (1.61%)
Prev Close:36.67
Open:37.25
Bid:35.33 x 200
Ask:36.83 x 200
1y Target Est:59.00
Day's Range:35.29 - 37.47
52wk Range:22.20 - 58.23
Volume:1,302,490
Avg Vol (3m):736,722
Market Cap:618.16M
P/E (ttm):N/A
EPS (ttm):-5.67
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add AMAG to Portfolio   Download Data

 HEADLINES 
•Early-Market Movers: China Agritech, Novavax Inc
at Fox Business (Tue 1:06AM)
•AMAG Defends Feraheme Safety: BioBuzz
at TheStreet.com (Mon, Feb 8)
•UPDATE - AMAG safety update on anemia drug lifts shares
at Reuters (Sat, Feb 6)
•AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Sat, Feb 6)
•AMAG Pharmaceuticals Provides Feraheme® Safety Update
Business Wire (Sat, Feb 6)
•Iron Safety Hits AMAG Pharmaceuticals
at Seeking Alpha (Fri, Feb 5)
•Thursday Options Update: GFI, SU, MA, ZION, DAL, AMAG & JWN
at Seeking Alpha (Fri, Feb 5)
•AMAG Pharma Tumbles on Feraheme Safety Concerns: BioBuzz
at TheStreet.com (Fri, Feb 5)
•Recent Dividend Hikes May Point to a Return to Normalcy
at Seeking Alpha (Mon, Jan 25)
•AMAG Pharma prices, expands stock offering
at bizjournals.com (Fri, Jan 22)
•Amag Pharmaceuticals prices 3.6M stock offering
AP (Thu, Jan 21)
•AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Sta
EDGAR Online (Thu, Jan 21)
•AMAG Pharmaceuticals Announces Pricing of Public Offering of 3,600,000 Shares of Common Stock
Business Wire (Thu, Jan 21)
More Headlines for AMAG...
 ANALYST 
EPS Est (next year) (Dec-09) :-5.51
EPS Est (in 2 years) (Dec-10) :-2.62
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic iron compounds to treat anemia in the United States, Europe, and Japan.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices